We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Three-Dimensional Printing of Living Tissues with Stem Cell Bioink

By LabMedica International staff writers
Posted on 05 Jul 2016
A recent paper described an advance in the use of three-dimensional printing that enables the use of the technique to print living tissues from a bioink that contains stem cells and nutrients.

Investigators at the University of Bristol (United Kingdom) compounded the bioink from two different polymer components. More...
The first component was a seaweed extract that provided structural support, while the second component was a synthetic polymer – already approved for medical applications – that produced a liquid to solid-state change when the temperature of the medium was raised.

The paper, which was published in the June 22, 2016, online edition of the journal Advanced Healthcare Materials, described the differentiation of stem cells into osteoblasts and chondrocytes) and the use of this material to generate three-dimensional printed tissue structures over a period five weeks, including a full-size tracheal cartilage ring.

Senior author Dr. Adam Perriman, a senior research fellow at the University of Bristol, said, "Designing the new bioink was extremely challenging. You need a material that is printable, strong enough to maintain its shape when immersed in nutrients, and that is not harmful to the cells. We managed to do this, but there was a lot of trial and error before we cracked the final formulation. The special bioink formulation was extruded from a retrofitted benchtop three-D printer, as a liquid that transformed to a gel at 37 degrees Celsius, which allowed construction of complex living three-D architectures."

Dr. Perriman said, "What was really astonishing for us was when the cell nutrients were introduced, the synthetic polymer was completely expelled from the three-D structure, leaving only the stem cells and the natural seaweed polymer. This, in turn, created microscopic pores in the structure, which provided more effective nutrient access for the stem cells.

Related Links:
University of Bristol



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Clinical Informatics Platform
CLARION™
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.